Back to Journals » Neuropsychiatric Disease and Treatment » Volume 9
A validation study of the Chinese-Cantonese Addenbrooke’s Cognitive Examination Revised (C-ACER)
Authors Wong LL, Chan CC, Leung JL, Yung CY , Wu KK, Cheung SYY, Lam CLM
Received 20 March 2013
Accepted for publication 9 April 2013
Published 7 June 2013 Volume 2013:9 Pages 731—737
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 5
LL Wong,1 CC Chan,2 JL Leung,1 CY Yung,2 KK Wu,3 SYY Cheung,3 CLM Lam4
1Department of Psychiatry, 2Department of Medicine and Geriatrics, United Christian Hospital, Kwun Tong, Kowloon, Hong Kong; 3Clinical Psychology Services, Kwai Chung Hospital, Kwai Chung, New Territories, Hong Kong; 4Hong Kong Federation of Youth Groups, Department of Clinical Psychology, Tseung Kwan O Hospital, Tseung Kwan O, New Territories, Hong Kong
Background: There is no valid instrument for multidomain cognitive assessment to aid the detection of mild cognitive impairment (MCI) and mild dementia in Hong Kong. This study aimed to validate the Cantonese Addenbrooke’s Cognitive Examination Revised (C-ACER) in the identification of MCI and dementia.
Methods: 147 participants (Dementia, n = 54; MCI, n = 50; controls, n = 43) aged 60 or above were assessed by a psychiatrist using C-ACER. The C-ACER scores were validated against the expert diagnosis according to DSM-IV criteria for dementia and Petersen criteria for MCI. Statistical analysis was performed using the receiver operating characteristic method and regression analyses.
Results: The optimal cut-off score for the C-ACER to differentiate MCI from normal controls was 79/80, giving the sensitivity of 0.74, specificity of 0.84 and area under curve (AUC) of 0.84. At the optimal cut-off of 73/74, C-ACER had satisfactory sensitivity (0.93), specificity (0.95) and AUC (0.98) to identify dementia from controls. Performance of C-ACER, as reflected by AUC, was not affected after adjustment of the effect of education level. Total C-ACER scores were significantly correlated with scores of global deterioration scale (Spearman’s rho = −0.73, P < 0.01).
Conclusion: C-ACER is a sensitive and specific bedside test to assess a broad spectrum of cognitive abilities, and to detect MCI and dementia of different severity. It can be used and interpreted with ease, without the need to adjust for education level in persons aged 60 or above.
Keywords: dementia, mild cognitive impairment, multidomain, bedside, assessment, Hong Kong
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.